You're scaling — but revenue is unpredictable at the board level. The Compound path builds a durable, compounding growth architecture with board-level pipeline visibility guaranteed in the contract.
You're past early traction — revenue is moving, the team is growing, and you're in board meetings where pipeline confidence matters. But the underlying architecture isn't built for compounding growth at this scale yet.
At the Compound stage, all 6 risk domains carry board-level financial exposure. The Stress Test quantifies them. The Compound path eliminates them.
At scale, is your pipeline coverage ratio defensible in a board meeting — or is it covering structural fragility behind a large headline number?
As you move upmarket, are your conversion assumptions calibrated to the new motion — or inherited from an earlier, easier-to-close segment?
Does your growth model compound naturally, or does it require proportional effort increases to sustain — a ceiling problem waiting to surface?
At scale, CRM data becomes the board's source of truth. Is yours giving an accurate picture, or is attribution creating false confidence?
As deal complexity grows, where is revenue being lost between signal and close — and how much does that compound across a full quarter?
Is the architecture built to compound as the team scales — or will it require a rebuild at 50 reps that the board wasn't expecting?
$2,500 to underwrite your revenue architecture. Carry it forward into Compound within 60 days.